|
Forecast
Period
|
2024-2028
|
|
Market
Size (2022)
|
USD 715.48 Million
|
|
CAGR
(2023-2028)
|
6.22%
|
|
Fastest
Growing Segment
|
Hospitals
|
|
Largest
Market
|
Germany
|
Market Overview
Europe Vascular Graft
Market has valued at USD 715.48 Million in 2022 and is anticipated to project impressive
growth in the forecast period with a CAGR of 6.22% through 2028. Vascular
grafts, also known as blood vessel grafts, are crucial medical devices used in
vascular bypass procedures. These procedures involve redirecting the flow of
blood from one part of the body to another by reconnecting the blood vessels.
Vascular grafts are manufactured using a variety of materials, including
polyurethane (PU), biosynthetic, polyester, and polytetrafluoroethylene (PTFE). One of the primary
purposes of vascular grafts is to replace injured or damaged veins, arteries,
blood vessels, and valves during organ transplantation or hemodialysis, a
process used to filter waste and excess fluid from the blood in individuals
with kidney failure. Additionally, they are employed in cases of vascular
occlusion, aneurysms, and coronary artery diseases. By providing structural
support and promoting the healing process, vascular grafts help reduce blood
leakage and facilitate the invasion of healthy cells from the adventitia
without negatively affecting the endothelialization rate. Some common types of
vascular grafts include hemodialysis access grafts, coronary artery grafts,
endovascular stents, and peripheral vascular grafts. These specialized products
cater to the unique needs of different medical procedures and conditions,
ensuring optimal outcomes for patients.
Key Market Drivers
Increasing
Prevalence of Cardiovascular Disorders
The increasing prevalence
of cardiovascular disorders in Europe is undeniably bolstering the demand for
vascular grafts, positioning these medical devices at the forefront of modern
healthcare. Cardiovascular diseases, including coronary artery disease,
peripheral arterial disease, and aortic aneurysms, have become a growing health
concern across the continent, primarily due to factors like an aging
population, sedentary lifestyles, and dietary habits. Consequently, the demand
for effective treatment options, such as vascular grafts, has soared.
Vascular grafts play a
pivotal role in addressing the intricate challenges posed by cardiovascular
disorders. They provide crucial solutions for patients with arterial blockages,
damaged blood vessels, or those requiring bypass surgery. As the prevalence of these
conditions rises, so does the necessity for vascular grafts, which can restore
proper blood flow, prevent complications like limb amputations, and ultimately
save lives.
Moreover, advancements in
medical technology and surgical techniques have made vascular graft procedures
safer and more accessible, encouraging their widespread adoption. Minimally
invasive approaches and the development of endovascular grafts have reduced the
morbidity associated with traditional open surgeries, making graft placement a
viable option for a broader spectrum of patients, including those who are
elderly or have comorbidities. The increasing prevalence of cardiovascular
disorders in Europe is driving up the demand for vascular grafts, as these
devices represent a crucial lifeline for individuals suffering from these
conditions. The ongoing commitment to research and innovation in the field of
vascular surgery is likely to further amplify the role of vascular grafts in
addressing the continent's cardiovascular health challenges.
Technological
Advancements in the Scaffold Material and Design of Vascular Grafts
Technological advancements
in scaffold materials and the design of vascular grafts have catalyzed a
significant surge in demand for these life-saving medical devices in Europe.
Vascular grafts are essential in treating a wide array of cardiovascular
conditions, including arterial blockages, aneurysms, and vascular trauma, and
their evolution is transforming the landscape of vascular surgery. Traditional
grafts were often prone to complications like thrombosis or graft failure, but
modern scaffold materials, such as biodegradable polymers and bioengineered
tissues, offer improved performance and reduced risk of adverse events. These
materials not only mimic the mechanical properties of natural blood vessels but
also encourage tissue integration, minimizing the chances of graft rejection.
Furthermore, advancements
in graft design have led to more tailored solutions for individual patients.
Customizable grafts, created using cutting-edge 3D printing and computer-aided
design technologies, allow surgeons to match the graft precisely to the
patient's unique anatomical requirements. This personalization not only
enhances the success rate of graft procedures but also reduces the likelihood
of postoperative complications, making vascular grafts a more attractive option
for both patients and healthcare providers.
In addition, these
innovations have shortened recovery times, decreased hospital stays, and
improved overall patient outcomes, making vascular grafts an increasingly
favored treatment option in Europe's aging population. As the region continues
to invest in research and development, coupled with a growing awareness of
these technological advancements, the demand for vascular grafts is expected to
soar, ensuring that patients receive the best possible care for their
cardiovascular conditions.
Rising
Healthcare Expenditure
The escalating healthcare
expenditure in Europe is undeniably contributing to the increasing demand for vascular
grafts, highlighting the pivotal role these medical devices play in
contemporary healthcare. As healthcare systems grapple with the financial
burden of addressing a myriad of medical conditions, including cardiovascular
disorders, the demand for effective treatments like vascular grafts is on the
rise.
The growing healthcare
expenditure is partly driven by the continent's aging population, as elderly
individuals are more susceptible to cardiovascular diseases, often requiring
complex interventions. Vascular grafts are integral in these scenarios, as they
can provide critical solutions for patients with arterial blockages, aneurysms,
or damaged blood vessels. The cost-effectiveness of vascular grafts in
preventing costly long-term complications, such as limb amputations or
extensive hospital stays, makes them an attractive option in the context of
healthcare budget considerations.
Furthermore, ongoing
advancements in medical technology have allowed for more precise and minimally
invasive graft placement procedures, reducing both the overall cost of
treatment and the financial burden on patients and healthcare systems. These
developments make vascular grafts not only life-saving but also cost-effective
solutions, aligning with the fiscal challenges faced by European healthcare
systems.
Increasing
Demand for The Technologically Advanced Products
The surging demand for
technologically advanced vascular grafts in Europe is emblematic of the
ever-evolving landscape of healthcare and the growing expectations for
cutting-edge medical solutions. This trend is propelled by several key factors,
primarily the European population's increasing awareness of advanced medical
treatments and their rising expectations for superior healthcare outcomes.
In an era characterized by
rapid technological innovation, patients and healthcare providers alike are
seeking state-of-the-art solutions for complex medical conditions, including
cardiovascular disorders. Vascular grafts, equipped with the latest
advancements in materials and design, align perfectly with this demand.
Advanced materials like biodegradable polymers and bioengineered tissues not
only enhance the biocompatibility and durability of grafts but also promote
seamless integration with the patient's own vascular system, reducing the risk
of complications.
Moreover, the introduction
of cutting-edge technologies such as 3D printing and computer-aided design has
enabled the customization of vascular grafts to match each patient's unique
anatomical requirements. This level of personalization not only improves the
chances of successful graft procedures but also fosters trust and confidence
among patients, who increasingly seek tailored medical solutions. The pursuit
of technologically advanced vascular grafts is not only driven by patients but
also by healthcare providers who strive to offer the best available treatments.
These grafts, with their enhanced performance and reduced risk profiles, lead
to shorter recovery times, reduced hospital stays, and improved overall patient
outcomes, thus further fueling their demand in the European healthcare
landscape.
Download Free Sample Report
Key Market Challenges
Unfavorable
Reimbursement Scenario
The demand for vascular
grafts in Europe is facing a challenging landscape due to the unfavorable
reimbursement scenario prevalent in many healthcare systems across the
continent. This critical issue has a substantial impact on both patients and
healthcare providers, ultimately leading to a decrease in the utilization of
these vital medical devices.
In Europe, reimbursement
policies and rates for medical procedures and devices are subject to stringent
regulations and budget constraints within national healthcare systems. Vascular
grafts, despite their proven effectiveness in treating cardiovascular
conditions, often face limitations in terms of reimbursement, which can result
in higher out-of-pocket costs for patients or financial constraints for
hospitals and clinics. This unfavorable reimbursement scenario can deter both
patients and healthcare providers from choosing vascular grafts as a treatment
option, opting instead for alternative, less costly treatments.
Furthermore, the financial
burden associated with unfavorable reimbursement can have a cascading effect on
the healthcare industry. Hospitals and healthcare facilities may be reluctant
to invest in the latest technological advancements or may prioritize
cost-effective alternatives, potentially compromising the quality of care
provided to patients with cardiovascular disorders.
High
Risk Associated with Graft Failures
The demand for vascular
grafts in Europe is experiencing a decline owing to the high risk associated
with graft failures. Vascular grafts are essential medical devices used to
treat various cardiovascular conditions; however, their effectiveness is often
compromised by the inherent risks of graft failure, which have led to patient
apprehension and healthcare provider reluctance. Graft failure due to
thrombosis can necessitate repeat surgeries, extended hospital stays, and
increased healthcare costs, causing both patients and providers to reconsider
the use of vascular grafts.
Moreover, the long-term
durability of vascular grafts remains a significant concern. Over time, grafts
may degrade or become obstructed due to factors like material fatigue,
inflammation, or infection. This uncertainty surrounding the longevity of
grafts has led some patients and healthcare providers to seek alternative
treatment options with a more predictable track record. Additionally,
graft-related infections pose a substantial risk, especially in cases where the
graft must be removed to mitigate the infection. This scenario can result in
life-threatening complications and further deter the use of vascular grafts.
To counteract these issues
and boost the demand for vascular grafts, ongoing research and development
efforts focus on enhancing graft materials, design, and monitoring techniques.
The aim is to reduce the risks associated with graft failures and provide
patients and healthcare providers with greater confidence in the long-term
success of these vital medical devices. By addressing these challenges, the
demand for vascular grafts in Europe may see a resurgence as they become safer
and more reliable tools in the fight against cardiovascular diseases.
Key Market Trends
Technological
Improvements
Technological improvements
play a crucial role in shaping the vascular grafts market, with significant
positive impacts anticipated during the forecast period. To meet the growing
market demand, vendors are continuously innovating and introducing technologically
advanced products. For instance, in 2017, Vascular Flow Technologies
collaborated with Biovic, a Malaysian biomedical business, to develop the
groundbreaking Avatar Spiral Laminar Flow (SLF) vascular graft. This innovative
graft design aims to optimize blood flow and enhance patient outcomes.
Additionally, LeMaitre Vascular introduced the Omniflow II Biosynthetic
Vascular graft for Peripheral Revascularization and AV Access. This graft is
specifically engineered to provide superior strength and durability,
effectively resisting the formation of aneurysms even years after implantation.
These remarkable advancements across the product segment of vascular grafts are
expected to further propel market growth, offering improved treatment options
and better patient care.
Alarming
Rise in End Stage Renal Disease Prevalence
The alarming rise in the
prevalence of end-stage renal disease (ESRD) in Europe is undeniably increasing
the demand for vascular grafts, highlighting their critical role in the
management of this growing healthcare challenge. ESRD, often stemming from
chronic kidney disease, necessitates renal replacement therapy, which includes
hemodialysis, peritoneal dialysis, or kidney transplantation. Vascular grafts
play a pivotal role in facilitating these treatments, and as the number of
individuals requiring renal replacement therapy surges, so does the demand for
reliable vascular access solutions. In response to this burgeoning healthcare
challenge, research and development efforts are focused on improving graft
materials, design, and implantation techniques to enhance their longevity and
minimize complications. By addressing the specific needs of ESRD patients and
the vascular challenges associated with renal replacement therapy, these
innovations aim to meet the growing demand for vascular grafts in Europe and
provide better outcomes and quality of life for those battling end-stage renal
disease.
Segmental Insights
Raw Material Insights
Based on raw material, during the forecast period, the
polyester grafts segment is expected to experience significant expansion. This
growth can be attributed to recent advancements in polyester graft technology,
which have facilitated its rapid adoption in various medical applications. For
example, the combination of polyester grafts with collagen has been
instrumental in the development of biosynthetic grafts, offering improved
tensile strength and reducing the likelihood of graft rejection. These
advancements in polyester graft technology are poised to drive the growth of
the industry. Furthermore, the high demand for polyester grafts can be
attributed to their associated advantages, such as longer lifespan and blood
compatibility, which further contribute to the expansion of the segment. With
these advancements and advantages, the polyester grafts segment is expected to
witness a positive trajectory in the coming years.
End User Insights
Based on the end user, the hospitals segment emerged
as the largest market share holder. With their ability to offer a wide array of
treatments, ranging from cardiothoracic surgery to hemodialysis procedures,
hospitals play a crucial role in providing care to patients with complex
medical conditions. This comprehensive range of services is expected to drive
the adoption rate of vascular graft products, further contributing to the
growth of this segment in the future.
Moreover, the increasing number of admissions in
hospital settings for various procedures will also contribute to the segment's
growth over time. Additionally, the presence of new clinical trials being
conducted in multi-specialty hospitals presents exciting opportunities for
patients to explore and benefit from new experimental therapies. These trials
not only expand the available treatment options but also pave the way for
advancements in medical research and patient care. Overall, the hospitals
segment is poised for continued growth and innovation, fueled by its diverse
range of treatments, expanding patient base, and ongoing clinical trials
conducted within multi-specialty healthcare settings.
Country
Insights
The United Kingdom (UK) is
projected to dominate the vascular graft market in Europe. One of the key
drivers of this dominance is the growing geriatric population across the country.
With more than 5.5 million people aged 65 and above estimated by the World
Health Organization (WHO) to be living in the UK by 2020, the demand for
vascular grafts is expected to increase significantly.
Furthermore, the
development of minimally invasive endovascular aneurysm repair techniques is
anticipated to contribute to the surge in demand for procedures among elderly
individuals. As a result, healthcare professionals are likely to opt for
vascular graft products to meet the rising demand for such procedures. The
increasing demand for vascular grafts in the UK is indicative of the importance
of these medical devices in addressing the healthcare needs of the aging
population. It highlights the crucial role that vascular grafts play in
enabling healthcare professionals to provide effective treatment options for
patients in need.
Download Free Sample Report
Recent Developments
- Xeltis, a company specializing in advanced
cardiovascular implants based in Eindhoven, the Netherlands, has announced the
successful closure of an additional €12.5 million in funding from the European
Innovation Council (EIC) Fund.
Key Market Players
- B Braun
Medical A/S
- Cardinal Health Inc.
- Endologix llc
- Cook Medical
- Medtronic plc
- Terumo Corporation
- LeMaitre Vascular, Inc.
- Getinge AB
- C.R. Bard
- W.L. Gore and Associates, Inc.
|
By
Indication
|
By
Raw Material
|
By
End User Industry
|
By
Country
|
- EVAR
- Abdominal
Aneurysm Repair
- Thoracic
Aneurysm
- Peripheral
Vascular Repair
|
- Polyester
- ePTFE
- Polyurethane
- Polyamide
- Biosynthetic
|
- Hospital
- Ambulatory
Surgery Center
|
- Germany
- France
- United
Kingdom
- Italy
- Spain
- Russia
- Poland
|
Report
Scope:
In this report, the Europe
Vascular Graft Market has been segmented into the following categories, in
addition to the industry trends which have also been detailed below:
- Europe Vascular Graft Market, By Indication:
o
EVAR
o
Abdominal Aneurysm
Repair
o
Thoracic Aneurysm
o
Peripheral Vascular
Repair
- Europe Vascular Graft Market, By Raw Material:
o
Polyester
o
ePTFE
o
Polyurethane
o
Polyamide
o
Biosynthetic
- Europe Vascular Graft Market, By End User Industry:
o
Hospital
o
Ambulatory Surgery
Center
- Europe Vascular Graft Market, By Country:
o Germany
o France
o United
Kingdom
o Italy
o Spain
o Russia
o Poland
Competitive
Landscape
Company
Profiles: Detailed analysis of the major companies present in
the Europe Vascular Graft Market.
Available
Customizations:
Europe Vascular Graft
Market report with the given market data, Tech Sci Research offers
customizations according to a company's specific needs. The following
customization options are available for the report:
Company
Information
- Detailed
analysis and profiling of additional market players (up to five).
Europe Vascular
Graft Market is an upcoming report to be released soon. If you wish an early
delivery of this report or want to confirm the date of release, please contact
us at [email protected]